Latest News in Pharma industry

Fatal Health Scandal: Kobayashi's Red Yeast Rice Linked to Deaths and Kidney Damage
Semler Scientific Invests $40M in Bitcoin
IGC Pharma Begins Phase II Trial for IGC-AD1 Therapy
Merck & Co. to Acquire Eyebiotech Ltd. for $3 Billion
Asahi Kasei Corp. Acquires Calliditas Therapeutics for $1.1B
J&J's Prostate Cancer Radiotherapy Faces Setbacks
Melinda French Gates Grants $1 Billion for Women's and Family Support
Rakuten Medical Reports Promising Results for Cancer Therapy Trial
TILT Biotherapeutics Reports Positive Results in Treating Ovarian Cancer
Transcenta Announces Promising Results in HER2-Negative Metastatic Gastric Cancer Trial
Spectrum.Life Raises €17 Million in Funding
US Butyl Acetate Prices Decline Amid Market Shifts
Medical Aesthetics Market Slows, New Growth Opportunities Emerge
HI-Bio's Felzartamab Shows Promise in Treating AMR
AstraZeneca & Daiichi Sankyo Report Positive Results in Lung Cancer Trial
Thriving Market for GLP-1 Medications: A $100 Billion Opportunity by 2030
Avian Influenza Outbreak Hits Australian Poultry Industry
Xi Jinping Leads Symposium with Enterprise and Expert Representatives
Novo Nordisk's Icodec Rejected by U.S. Health Regulators
Cencora Pharmaceutical Cyberattack Exposing Patient Medical Info
New Antibody Drug Conjugate Shows Promising Results in Phase I Study
Merck & Co (MSD) Reports Promising Results for New Cancer Treatment
Abdera Therapeutics Gets FDA Approval for ABD-1 Clinical Trial
Terran Biosciences Initiates Phase I Trials for TerXT in Schizophrenia Treatment
Verastem Oncology Announces Positive Results for Pancreatic Cancer Treatment
Cardiff Healthtech Company Secures £2.1M Funding for Digital Medical Solutions
Bicycle Therapeutics Raises $555M for Cancer Treatment Innovation
Resilience Secures $25M Funding for Healthtech Expansion
Challenges Persist for NHS in Cell and Gene Therapy Trials
Cannabis Surpasses Daily Drinking in US
Rite Aid's Creditors Seek Fee Reduction Amid Bankruptcy Struggles
Boehringer Ingelheim Acquires Preclinical Oncology Asset for Cancer Treatment Expansion
Asset Management Firms Adjust Ethereum ETF Filings
Elixir Medical's Lithotripsy System Shows Promise in Treating Coronary Artery Lesions
Enifer Secures €36M for Groundbreaking Food-Grade Factory
Adlai Nortye Launches Phase II ARTEMIS Trial
Scottish Biotech Company Completes Successful Phase I Trial for H-Guard
Pfizer's $1.5B Cost-Reduction Program Unveiled
H5N1 Bird Flu Case Reported in Michigan Dairy Farm Worker
Roche's Inavolisib Receives Expedited FDA Review
Link Found Between Ultra-Processed Foods and Stroke Risk
Study Reveals Impact of Microplastics on Male Reproductive Health
Fidelity Amends Ether ETF Filing
SonarMD Reduces Hospital Visits for IBD Patients Using Digital Platform
FDA Committee Recommends Using MRD as Surrogate Endpoint for Myeloma Therapies
Tempus AI Files for IPO to Revolutionize Medical Data Processing
NPPA Reduces Prices of Essential Drugs in India
LabGenius Raises £35M in Series B Funding
GSK's Experimental Drug Shows Promise in Reducing Asthma Attacks
Eventbrite Crackdown on Illegal Listings and Scammers
Load More